Nasotracheal Intubation With VL vs DL in Infants Trial

NCT05433155 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 680

Last updated 2025-03-28

No results posted yet for this study

Summary

Nasotracheal Intubation with Videolaryngoscopy versus Direct Laryngoscopy in Infants (NasoVISI) Trial is a prospective randomized multicenter study. The study will be conducted at 8 centers in the United States. It is expected that approximately 700 subjects enrolled to product 670 evaluable subjects.The randomization is 1:1 naso tracheal intubation with the Storz C-Mac Video Videolaryngoscopy (VL) or the Standard Direct Laryngoscope (DL). The primary objective is to compare the nasotracheal intubation (NTI) first attempt success rate using VL vs. DL in infants 0-365 days of age presenting for cardiothoracic surgery and cardiac catheterizations.

Conditions

  • Intubation Complication
  • Intubation; Difficult or Failed
  • Hypoxia
  • Hypoxemia
  • Anesthesia Intubation Complication
  • Pediatric HD

Interventions

DEVICE

Nasotracheal intubation

Nontracheal intubation using clinical standard videolaryngoscopy or direct laryngoscopy

Sponsors & Collaborators

  • Children's Hospital Colorado

    collaborator OTHER
  • Seattle Children's Hospital

    collaborator OTHER
  • Baylor College of Medicine

    collaborator OTHER
  • Children's Medical Center Dallas

    collaborator OTHER
  • Dell Children's Medical Center of Central Texas

    collaborator OTHER
  • Children's National Research Institute

    collaborator OTHER
  • Vanderbilt University Medical Center

    collaborator OTHER
  • Children's Hospital of Philadelphia

    lead OTHER

Principal Investigators

  • Annery Garcia-Marcinikiewicz, MD · The Children Hospital of Philadelphia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
1 Day
Max Age
365 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-06
Primary Completion
2025-02-25
Completion
2025-02-25

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05433155 on ClinicalTrials.gov